Trial · NCT07911488
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in the Bain & Findley Activities of Daily Living (BF-ADL) composite score at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36 and Post Treatment Weeks 1, 4 and 8 | |
| Primary | Change from baseline in the TETRAS PRO composite score at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in the QUEST PRO weighted index score at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in the EQ-5D-5L index value at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in WPAI (Work Productivity and Activity Impairment) domain scores at each scheduled assessment. | Baseline to Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in Patient Global Impression of Severity (PGI-S) at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36 and Post Treatment Weeks 1, 4 and 8 | |
| Primary | Evaluation of participant therapy usage up to each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Evaluation of changes in the type, frequency, or dosage of tremor-related medications during the 36-month study period. | Up to 36 months | |
| Primary | Assessment of participant overall experience with the Encora X1™ device through Patient Experience Survey. | Months 1, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in each of the 25 individual Bain & Findley Activities of Daily Living (BF-ADL) item scores at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in each of the 14 individual TETRAS PRO item scores at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline to each scheduled assessment timepoint in daily evaluation based metrics using tremor power from postural hold. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline to each scheduled assessment timepoint in daily evaluation based metrics using modified PGI-S. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline to each scheduled assessment timepoint in daily evaluation based metrics using modified PGI-C. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07911488/registered